Clinical Trial Update: BR Combined With OR in Treatment-naïve Marginal Zone Lymphoma [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study evaluating BR combined with OR in treatment-naïve marginal zone lymphoma; recruitment status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marginal Zone Lymphoma

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Marginal Zone Lymphomas | Phase 2 | Status: NOT_YET_RECRUITING